Sangamo Biosciences reported $1.62M in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.23M 20K
Avrobio Inc AVRO:US USD 4K 0
Bayer BAYN:GR EUR 2.52B 0
Biogen BIIB:US USD 100K 0
Biomarin Pharmaceutical BMRN:US USD 186K 0
Bluebird Bio BLUE:US USD 829K 94K
Gilead Sciences GILD:US USD 1000K 0
GlaxoSmithKline GSK:LN GBP 1.35B 0
Intercept Pharmaceuticals ICPT:US USD 41K 11K
Karyopharm Therapeutics KPTI:US USD 8K 0
Merk MRK:US USD 1.79B 0
Novartis NOVN:VX USD 890M 0
Omeros OMER:US USD 627K 0
Regulus Therapeutics RGLS:US USD 17K 2K
Roche Holding ROG:VX 107M 53M
Sangamo Biosciences SGMO:US USD 1.62M 85K
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 70K 0
Vertex Pharmaceuticals VRTX:US USD 2.6M 0
Ziopharm Oncology ZIOP:US USD 216K 0